|
FY2014
12 months to Dec 31, 2014
|
FY2013
12 months to Dec 31, 2013
|
FY2012
12 months to Dec 31, 2012
|
FY2011
12 months to Dec 31, 2011
|
FY2010
12 months to Dec 31, 2010
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of sales | |||||
| Cost of sales - restructuring | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Selling, general and administrative | |||||
| Research and development | |||||
| Amortization of intangible assets | |||||
| BioMimetic impairment charges | |||||
| Gain on Disposition of Intangible Assets | |||||
| Restructuring charges | |||||
| Total operating expenses | |||||
| Operating income | |||||
| Interest expense, net | |||||
| Other expense, net | |||||
| Income (loss) before income taxes | |||||
| Provision (benefit) for income taxes | |||||
| Income (Loss) from Continuing Operations Attributable to Parent | |||||
| Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent | |||||
| Net (loss) income | |||||
| Net income (loss) per share (Note 15): | |||||
| Basic (in dollars per share) | |||||
| Income (Loss) from Continuing Operations, Per Basic Share | |||||
| Diluted (in dollars per share) | |||||
| Income (Loss) from Continuing Operations, Per Diluted Share | |||||
| Weighted-average number of shares outstanding-basic (in shares) | |||||
| Weighted-average number of shares outstanding, diluted (in shares) | |||||
Loading...
